In particular, SNHG5 upregulates GSK3β by competitively binding miR-26a-5p in HCC, thereby aberrantly activating Wnt/β-catenin signaling and inducing EMT, which contributes to invasion and metastasis [32]. Here, GSK3B is linked to hepatocellular carcinoma.